← Back
Data updated: Mar 10, 2026
PARATEK PHARMS
Infectious DiseaseDermatology
PARATEK PHARMS is a specialty pharmaceutical company focused on Infectious Disease, Dermatology. Key products include NUZYRA.
2017
Since
2
Drugs
-
Trials
3
Approved (2yr)
Key Drugs
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 50%
1 drugs
Dermatology 50%
1 drugs
Pipeline Strength Pro
Loading...